| 36.65 -0.23 (-0.62%) | 10-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 44.96 | 1-year : | 52.52 |
| Resists | First : | 38.5 | Second : | 44.96 |
| Pivot price | 36.45  |
|||
| Supports | First : | 34.91 |
Second : | 32.7 |
| MAs | MA(5) : | 36.64  |
MA(20) : | 36.13 |
| MA(100) : | 37.44 |
MA(250) : | 39.54 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 47.4 |
D(3) : | 54.3 |
| RSI | RSI(14): 55.4 |
|||
| 52-week | High : | 55 | Low : | 31.75 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ OMCL ] has closed below upper band by 42.1%. Bollinger Bands are 59.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 37.41 - 37.61 | 37.61 - 37.78 |
| Low: | 34.88 - 35.17 | 35.17 - 35.4 |
| Close: | 36.22 - 36.65 | 36.65 - 37.01 |
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Fri, 30 Oct 2026
Omnicell Inc (OMCL) (Q3 2026) Earnings Call Highlights: Revenue - GuruFocus
Thu, 29 Oct 2026
Omnicell, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Thu, 29 Oct 2026
Omnicell (OMCL) Q3 2026 Earnings Call Transcript - The Globe and Mail
Thu, 29 Oct 2026
Omnicell (NASDAQ:OMCL) Profit Beat and Raised Guidance Offset Soft Q4 Revenue Outlook - ChartMill
Thu, 29 Oct 2026
(OMCL) Omnicell, Inc. Expects Q4 Revenue Range $295.0M - $301.0M - www.marketscreener.com
Thu, 29 Oct 2026
Earnings Flash (OMCL) Omnicell, Inc. Posts Q3 Adjusted EPS $0.58 per Share, vs. FactSet Est of $0.42 - marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 45 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 109.1 (%) |
| Shares Short | 3,640 (K) |
| Shares Short P.Month | 3,290 (K) |
| EPS | 0.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.31 |
| Profit Margin | 3.1 % |
| Operating Margin | 5.9 % |
| Return on Assets (ttm) | 1.5 % |
| Return on Equity (ttm) | 3 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 12.06 |
| Sales Per Share | 27.48 |
| EBITDA (p.s.) | 1.8 |
| Qtrly Earnings Growth | 333.2 % |
| Operating Cash Flow | 181 (M) |
| Levered Free Cash Flow | 134 (M) |
| PE Ratio | 43.63 |
| PEG Ratio | 15.3 |
| Price to Book value | 1.29 |
| Price to Sales | 1.33 |
| Price to Cash Flow | 9.18 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|